Published • loading... • Updated
Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment
Summary by 247wallst.com
1 Articles
1 Articles
Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment
The post Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment appeared first on 24/7 Wall St.. Abbott Laboratories (NYSE:ABT) and Danaher (NYSE:DHR) both closed the books on Q1 2026 with very different stories. Abbott leaned on consumer-facing devices and diagnostics that sit inside pharmacies and homes. Danaher leaned on bioprocessing tools and lab equipment sold to drugmakers. One business feels recessi…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
